I & V Bio India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 6.76 M
as on 31-07-2024
- Company Age 10 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.76 Cr
as on 31-07-2024
- Revenue -17.11%
(FY 2023)
- Profit 2.08%
(FY 2023)
- Ebitda -11.48%
(FY 2023)
- Net Worth 15.99%
(FY 2023)
- Total Assets -1.48%
(FY 2023)
About I & V Bio India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.76 M.
The company currently has active open charges totaling ₹10.76 Cr.
The Key Managerial Personnel (KMP) at I & V Bio India Private Limited India is Yarabolu Reddy as CEO. Thotli Reddy and Frank Indigne serve as directors at the Company.
- CIN/LLPIN
U05000TN2014PTC098614
- Company No.
098614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at I & V Bio India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thotli Reddy  | Managing Director | 26-Dec-2014 | Current |
| Yarabolu Reddy | CEO | 26-Apr-2022 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Frank Indigne  | Director | 26-Dec-2014 | Current |
Financial Performance of I & V Bio India.
I & V Bio India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.11% decrease. The company also saw a slight improvement in profitability, with a 2.08% increase in profit. The company's net worth Soared by an impressive increase of 15.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of I & V Bio India?
In 2023, I & V Bio India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Jun 2020 | ₹7.60 M | Open |
Others Creation Date: 29 Nov 2019 | ₹5.00 Cr | Open |
Others Creation Date: 29 Nov 2019 | ₹5.00 Cr | Open |
How Many Employees Work at I & V Bio India?
I & V Bio India has a workforce of 50 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of I & V Bio India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I & V Bio India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
.webp){kind=small}
